Citigroup’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-1,000
| Closed | -$1K | – | 7842 |
|
|
2020
Q4 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 7320 |
|
|
2020
Q3 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 7419 |
|
|
2020
Q2 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 7500 |
|
|
2020
Q1 | $1K | Hold |
1,000
| – | – | ﹤0.01% | 7556 |
|
|
2019
Q4 | $2K | Sell |
1,000
-60,438
| -98% | -$90.7K | ﹤0.01% | 7578 |
|
|
2019
Q3 | $91K | Sell |
61,438
-1,796
| -3% | -$2.91K | ﹤0.01% | 5746 |
|
|
2019
Q2 | $82K | Buy |
63,234
+1,738
| +3% | +$3.2K | ﹤0.01% | 6055 |
|
|
2019
Q1 | $161K | Buy |
61,496
+1,058
| +2% | +$2.48K | ﹤0.01% | 5307 |
|
|
2018
Q4 | $100K | Sell |
60,438
-2,133
| -3% | -$5.99K | ﹤0.01% | 5655 |
|
|
2018
Q3 | $304K | Buy |
62,571
+15,474
| +33% | +$87.7K | ﹤0.01% | 4824 |
|
|
2018
Q2 | $294K | Buy |
47,097
+43,866
| +1,358% | +$327K | ﹤0.01% | 4650 |
|
|
2018
Q1 | $26K | Buy |
3,231
+3,019
| +1,424% | +$28.8K | ﹤0.01% | 6610 |
|
|
2017
Q4 | $2K | Buy |
212
+138
| +186% | +$1.32K | ﹤0.01% | 7426 |
|
|
2017
Q3 | $1K | Sell |
74
-464
| -86% | -$3.53K | ﹤0.01% | 7192 |
|
|
2017
Q2 | $4K | Sell |
538
-109
| -17% | -$823 | ﹤0.01% | 6837 |
|
|
2017
Q1 | $5K | Buy |
647
+38
| +6% | +$236 | ﹤0.01% | 6817 |
|
|
2016
Q4 | $4K | Sell |
609
-3,720
| -86% | -$25.2K | ﹤0.01% | 6989 |
|
|
2016
Q3 | $28K | Sell |
4,329
-277
| -6% | -$2.19K | ﹤0.01% | 6037 |
|
|
2016
Q2 | $43K | Sell |
4,606
-813
| -15% | -$7.75K | ﹤0.01% | 5668 |
|
|
2016
Q1 | $58K | Buy |
5,419
+73
| +1% | +$770 | ﹤0.01% | 6039 |
|
|
2015
Q4 | $77K | Buy |
5,346
+5,195
| +3,440% | +$78.4K | ﹤0.01% | 5592 |
|
|
2015
Q3 | $3K | Buy |
+151
| New | +$3.33K | ﹤0.01% | 6961 |
|
Citigroup's NEOS Position: Q1 2021 in Review
Citigroup sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 1,000 shares — an estimated $1K sold.
Citigroup first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $304K in Q3 2018. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Citigroup reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Citigroup sold 1,000 Neos Therapeutics, Inc shares in Q1 2021, an estimated $1K.
- Citigroup first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- Citigroup's Neos Therapeutics, Inc position peaked at $304K in Q3 2018.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Citigroup's 13F filing for Q1 2021, filed 13 May 2021.